Damon R. Reed
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Childhood Cancer Survivors' Quality of Life, Cancer Genomics and Diagnostics, CAR-T cell therapy research
Most-Cited Works
- → Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial(2017)1,375 cited
- → Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology(2018)294 cited
- → Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial(2017)294 cited
- → NCCN Guidelines Insights: Bone Cancer, Version 2.2017(2017)293 cited
- → Quality of life in adolescent and young adult cancer patients: a systematic review of the literature(2015)271 cited
- → Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma(2019)254 cited